Variable | Non hesitant group (n = 99) | Hesitant group (n = 13) | P-value* |
---|---|---|---|
Gender | |||
Male | 16 | 1 | 0.67 |
Female | 82 | 12 | |
Transgender/nonbinary | 1 | 0 | |
Age (yr.) | |||
< 18 | 0 | 0 | |
18–30 | 8 | 2 | 0.58 |
31–40 | 9 | 0 | |
41–50 | 35 | 4 | |
51–60 | 23 | 5 | |
61–70 | 19 | 2 | |
> 70 | 5 | 0 | |
Ethnicity | |||
Hispanic | 87 | 13 | 0.68 |
Non-Hispanic | 7 | 0 | |
Not reported | 1 | 0 | |
Don't wish to reply | 2 | 0 | |
Missing | 2 | 0 | |
Racial identity | |||
Native American | 2 | 0 | 0.21 |
Asian, Native Hawaiian, Pacific Islander | 4 | 0 | |
Black | 3 | 0 | |
White | 21 | 0 | |
More than one | 5 | 1 | |
Unknown | 21 | 6 | |
Other | 16 | 4 | |
Missing | 26 | 2 | |
Highest level of formal Education | |||
No formal | 7 | 0 | 0.98 |
Some formal | 27 | 4 | |
High school | 34 | 5 | |
Some college credit | 12 | 1 | |
Trade/technical | 5 | 1 | |
Bachelor | 8 | 1 | |
Masters | 1 | 0 | |
Professional | 1 | 0 | |
Doctorate | 0 | 0 | |
Missing | 5 | 1 | |
Personal experience with COVID-19 | |||
I had Covid | 10 | 1 | 0.96 |
Family member had COVID | 14 | 2 | |
Someone I know personally had COVID | 20 | 2 | |
No one I know personally had COVID | 36 | 4 | |
Missing | 7 | 2 | |
Primary Rheumatological disease | |||
Rheumatoid arthritis | 58 | 8 | 0.47 |
SLE | 5 | 1 | |
Scleroderma | 2 | 1 | |
Sjogren | 2 | 0 | |
Vasculitis | 1 | 0 | |
Ankylosing Spondylitis | 1 | 1 | |
Others | 3 | 0 | |
Do not wish to reply | 2 | 1 | |
Missing | 7 | 1 | |
Years with disease | |||
1 yr | 9 | 2 | 0.92 |
1–5 years | 18 | 3 | |
5–10 years | 22 | 2 | |
10–20 years | 23 | 3 | |
> 20 years | 20 | 3 | |
Missing | 8 | 0 | |
Medication | |||
A doctor has discussed COVID vaccine with me | |||
Yes | 52 | 6 | 0.51 |
No | 42 | 7 | |
Missing | 6 | 0 | |
Language | |||
Spanish | 66 | 11 | 0.19 |
English | 33 | 2 | |
Medication | |||
Prednisone | 17 | 3 | 0.49 |
HCQ | 30 | 2 | |
MTX | 24 | 4 | |
Mycophenolate | 7 | 3 | |
Azathioprine | 3 | 0 | |
Tofacitinib | 4 | 0 | |
Injection | 18 | 2 | |
Infusion | 12 | 1 | |
Others | 10 | 3 | |
None | 0 | 0 | |
Primary source of information for COVID-19 | |||
Television | 56 | 6 | 0.30 |
Internet | 40 | 5 | |
Social media | 31 | 1 | |
Friends and/or family | 32 | 2 | |
Church | 8 | 0 | |
Doctor’s office | 24 | 1 |